Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Ginkgo Leaf Tablet for Mild to Moderate Vascular Dementia
CTR20211486Phase 3Completed
- Sponsor
- Fangsheng Pharmaceutical
- Start
- Jul 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of compound ginkgo biloba extract in vascular dementia, sponsored by Fangsheng Pharmaceutical. Started Jul 2021; status: completed.
02
Drugs
compound ginkgo biloba extract
03
Conditions
vascular dementia
Beyond the preview
Go deeper on CTR20211486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211486.